ALQGC.PA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 23:29):

Stats
今日成交量	21 296.00
平均成交量	112 230
市值	8.83M
EPS	€0 ( 2023-10-23 )
下一个收益日期	( €0 ) 2024-05-26
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-0.160
ATR14	€0 (0.00%)

Quantum Genomics SA 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Quantum Genomics SA 财务报表

Annual	2023
营收:	€10 060.00
毛利润:	€-3.02M (-29 979.73 %)
EPS:	€-0.0919

FY	2023
营收:	€10 060.00
毛利润:	€-3.02M (-29 979.73 %)
EPS:	€-0.0919

FY	2022
营收:	€2.52M
毛利润:	€-26.99M (-1 073.02 %)
EPS:	€-0.720

FY	2021
营收:	€116 211
毛利润:	€-1.63M (-1 403.14 %)
EPS:	€-0.158

Financial Reports:

No articles found.

Quantum Genomics SA

Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.